EMA ESTABLISHES ZIKA TASK FORCE AS PHARMACOS PONDER VACCINES
March 1st, 2016
THE EUROPEAN Medicines Agency (EMA) has established an expert task force on the Zika virus to advise pharmacos on securing market approval for new drugs. With no treatments currently approved and none undergoing clinical studies, EMA wants Zika medicines developed quickly. A communiqué said the taskforce “will be available to give advice on any scientific and regulatory matters for the research and development of medicines or vaccines against the virus.” This includes offering scientific advice on treatments that will mainly be used outside the EU, (Zika is ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.